Richard J. Honeywell
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Evaluation of MTH1 and DCTPP1 inhibitors in fluorocyclopentenylcytosine (RX-3117) resistant lung cancer cells and potential cross resistance patterns.
Journal: Nucleosides, nucleotides & nucleic acids
Published: June 05, 2026
Unraveling resistance mechanisms to the novel nucleoside analog RX-3117 in lung cancer: insights into DNA repair, cell cycle dysregulation and targeting PKMYT1 for improved therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 31, 2025
Radio-sensitizing effect of MEK inhibition in glioblastoma in vitro and in vivo.
Journal: Journal of cancer research and clinical oncology
Published: October 18, 2022
Carboplatin Dosing in Children Using Estimated Glomerular Filtration Rate: Equation Matters.
Journal: Cancers
Published: October 08, 2021
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study.
Journal: CPT: pharmacometrics & systems pharmacology
Published: August 09, 2021
Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 27, 2021
The prognostic impact of circulating miRNAs in patients with advanced esophagogastric cancer during palliative chemotherapy.
Journal: Cancer treatment and research communications
Published: January 15, 2021
Epithelial Transfer of the Tyrosine Kinase Inhibitors Erlotinib, Gefitinib, Afatinib, Crizotinib, Sorafenib, Sunitinib, and Dasatinib: Implications for Clinical Resistance.
Journal: Cancers
Published: October 28, 2020
11C-Sorafenib and 15O-H2O PET for Early Evaluation of Sorafenib Therapy.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 26, 2020
RX-3117 (Fluorocyclopentenyl-Cytosine)-Mediated Down-Regulation of DNA Methyltransferase 1 Leads to Protein Expression of Tumor-Suppressor Genes and Increased Functionality of the Proton-Coupled Folate Carrier.
Journal: International journal of molecular sciences
Published: January 14, 2020
Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome.
Journal: Cancers
Published: December 12, 2019
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: a phase I exposure escalation study.
Journal: Cancer chemotherapy and pharmacology
Published: December 06, 2019
Last Updated: 09/26/2026